Who
Jacob D. Cohen
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Mangoceuticals; Chief Executive Officer, American International Holdings; Chief Operating Officer, Artfest International.
In numbers
- Trades disclosed
- 37
- Buys
- 1
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 1 Mar 2008
- Last trade
- 11 Aug 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Aug 2026filed 6 Oct 2026 | MGRX MangoceuticalsProviders & Facilities | SEC FORM 4 Code G | —2,000,000 at $0.00 | filing |
| 11 Aug 2026filed 6 Oct 2026 | MGRX MangoceuticalsProviders & Facilities | SEC FORM 4 Code G | —2,000,000 at $0.00 | filing |
| 28 Jul 2026filed 6 Oct 2026 | MGRX MangoceuticalsProviders & Facilities | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 16 Mar 2026filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —50,000 at $0.00 | filing |
| 16 Mar 2026filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Mar 2026filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —83,333 at $0.00 | filing |
| 16 Mar 2026filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —83,333 at $0.00 | filing |
| 16 Mar 2026filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —2,000,000 at $0.00 | filing |
| 16 Mar 2026filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 19 Dec 2025filed 6 Oct 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code J | — | filing |
| 30 Sep 2025filed 6 Oct 2026 | MGRX MangoceuticalsProviders & Facilities | SEC FORM 4 Code G | —500,000 at $0.00 | filing |
| 30 Sep 2025filed 6 Oct 2026 | MGRX MangoceuticalsProviders & Facilities | SEC FORM 4 Code G | —500,000 at $0.00 | filing |
| 9 Sep 2025filed 20 Mar 2026 | MGRX MangoceuticalsProviders & Facilities | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 9 Sep 2025filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | — | filing |
| 9 Sep 2025filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 9 Sep 2025filed 20 Mar 2026 | MGRX MangoceuticalsProviders & Facilities | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 21 Jul 2025filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —50,000 | filing |
| 21 Jul 2025filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —2,000,000 | filing |
| 21 Jul 2025filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | — | filing |
| 21 Jul 2025filed 20 Mar 2026 | MGRX Mangoceuticalsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —50,000 | filing |
News
No headline names them, or the companies they trade most, lately.